Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group CoTSE:3353 +0.29%68 Debt-to-Equity is 0.66 as of Feb. 2026, which is 34% below its 10-year median of 1.00. GuruFocus rates TSE:3353 with a GF Score™ of 68/100 and a GF Value™ of 円3,614.66 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 508 Conglomerates companies, Medical Ikkou Group Co ranks worse than 54.92% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Medical Ikkou Group Co's Debt-to-Equity or its related term are showing as below:
TSE:3353'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.66 Med: 1 Max: 1.41
Current: 0.66
During the past 13 years, the highest Debt-to-Equity Ratio of Medical Ikkou Group Co was 1.41. The lowest was 0.66. And the median was 1.00.
TSE:3353's Debt-to-Equity is ranked worse than 54.92% of 508
companies
in the Conglomerates industry
Industry Median: 0.53
vs TSE:3353: 0.66
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Medical Ikkou Group Co Debt-to-Equity Related Terms
Medical Ikkou Group Co Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Medical Ikkou Group Co's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Medical Ikkou Group Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Ikkou Group Co Debt-to-Equity vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Medical Ikkou Group Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co (TSE:3353) has a Debt-to-Equity of 0.66 as of Feb. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Medical Ikkou Group Co and its competitors. This is 34% below median its historical median of 1.00. Over the past decade, Medical Ikkou Group Co's Debt-to-Equity has ranged from 0.66 to 1.41. According to the industry distribution chart, Medical Ikkou Group Co ranks #279 out of 508 companies in the Conglomerates industry, placing it in the top 54.9%.
Is Medical Ikkou Group Co's Debt-to-Equity too high?
Medical Ikkou Group Co's current Debt-to-Equity of 0.66 is 34% below median its 10-year median of 1.00. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 1.41. The Conglomerates industry median Debt-to-Equity is 0.53. Medical Ikkou Group Co's value of 0.66 is 24.5% above this industry median. Based on the distribution chart, Medical Ikkou Group Co ranks #279 out of 508 companies in the Conglomerates industry, which is below the industry midpoint. Overall, Medical Ikkou Group Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's Debt-to-Equity compare to MMM and HON?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #279 out of 508 companies for Debt-to-Equity. This places Medical Ikkou Group Co in the lower half of its industry. The industry median Debt-to-Equity is 0.53. Medical Ikkou Group Co's value of 0.66 is 24.5% above this benchmark. Historically, Medical Ikkou Group Co's own Debt-to-Equity has ranged from 0.66 to 1.41 over the past decade. While the company's 10-year median is 1.00 vs. the industry median of 0.53, Medical Ikkou Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Conglomerates company?
The median Debt-to-Equity among Conglomerates companies is 0.53, based on 508 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current Debt-to-Equity of 0.66 is 24.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median Debt-to-Equity is 0.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current Debt-to-Equity is 0.66, which is 34% below median its own 10-year median of 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,614.66, compared to a current price of 円2,813.00 — trading 22.2% below its estimated fair value. The current Debt-to-Equity is 0.66, which is 34% below median its 10-year median of 1.00 and 24.5% above the Conglomerates industry median of 0.53. Medical Ikkou Group Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current Debt-to-Equity is 0.66 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,813.00 is trading 22.2% below its estimated GF Value™ of 円3,614.66.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
Debt-to-Equity: 0.66 (34% below median its 10-year median of 1.00)
GF Value™: 円3,614.66 vs. price of 円2,813.00 (22.2% below fair value)
Industry Position: 24.5% above the Conglomerates median (#279 of 508)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
68GF Score
Get the complete analysis for TSE:3353
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
